NCT03108131 2025-05-28Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare TumorsM.D. Anderson Cancer CenterPhase 2 Completed49 enrolled 10 charts
NCT04088786 2022-05-06Phase I Trial HIPEC With Nal-irinotecanStony Brook UniversityPhase 1 Completed18 enrolled